Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,preMarketChange,preMarketChangePercent,preMarketTime,preMarketPrice,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceHint,regularMarketChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,priceEpsCurrentYear,currency,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchange,shortName,exchangeDataDelayedBy,market,marketState,epsTrailingTwelveMonths,epsForward,epsCurrentYear,twoHundredDayAverageChangePercent,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jun 14, 2021) 4","Short Ratio (Jun 14, 2021) 4","Short % of Float (Jun 14, 2021) 4","Short % of Shares Outstanding (Jun 14, 2021) 4","Shares Short (prior month May 13, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,ICUI,1294742000.0,21218800,10709000,,27092000,,23731000,72391000,112680000,29580000,29580000,,-161000,,,,3361000,318046000,288466000,205366000,-2488000,,23731000,23731000,193074000.0,701586000.0,244462000.0,1520768000.0,39564000.0,1765230000.0,2122000.0,46049000.0,832383000.0,22682000.0,32952000.0,-15323000.0,84980000.0,424249000.0,179862000.0,29115000.0,-9913000.0,507208000.0,928182000.0,18834000.0,13036000.0,124039000.0,300086000.0,73049000.0,-3034000,2411000,-18881000,-141000,-3000000,-24170000,4864000,28152000,-7723000,-1287000,51320000,24527000,13208000,1506000,8596000,-14028000,748320000.0,en-US,US,EQUITY,True,Delayed Quote,0.0,0.0,1630572224,200.38,96185,24.190002,0.13729498,176.19 - 227.07,-26.690002,-0.11754085,176.19,227.07,1620331200,1635937140,1636372800,46.287827,71.761,195.18143,5.198578,0.026634593,203.66093,-3.2809296,4251823360,25.428934,2,0.5166786,2.7923245,15,America/New_York,EDT,-14400000,198.475 - 200.59,199.35,200.38,260.0,8,8,finmb_317440,NasdaqGS,"ICU Medical, Inc.",USD,113031,28.54416,USD,False,False,200.38,1630526402,1.0299988,199.86,200.59,198.475,38342,NMS,"ICU Medical, Inc.",0,us_market,PRE,4.329,7.88,7.02,-0.016109765,0.59,,,227.07,176.19,195.18,203.66,113.03k,96.19k,21.22M,,19.92M,6.43%,96.77%,415.29k,3.89,2.84%,1.96%,440.63k,,,,,,0.00%,,,3:2,"Mar 17, 2002","Dec 30, 2020","Mar 30, 2021",7.44%,9.98%,4.39%,6.47%,1.26B,60.02,-3.20%,461.5M,212.64M,93.77M,4.33,41.00%,437.28M,20.63,51.37M,3.38,5.16,71.76,234.55M,149.25M,Value,92673,Healthcare,7900,5,3,"ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.",San Clemente,949 366 2183,CA,5,1609372800,1625011200,3,United States,http://www.icumed.com,86400,4,951 Calle Amanecer,949 366 8368,Medical Instruments & Supplies
t-1,ICUI,1272033000.0,21218800,11797000,,30109000,,26142000,73552000,119874000,34525000,34525000,,-108000,,,,3967000,320451000,285926000,200577000,-4416000,,26142000,26142000,197231000.0,693068000.0,261426000.0,1502265000.0,36617000.0,1763691000.0,2106000.0,44801000.0,808652000.0,22531000.0,33001000.0,-1561000.0,83594000.0,396097000.0,195488000.0,31034000.0,-1522000.0,516114000.0,920777000.0,12974000.0,16040000.0,127769000.0,314928000.0,71864000.0,-15222000,-8383000,-40903000,-126000,4426000,-10686000,4607000,45104000,-55000,3055000,78526000,23951000,10337000,39116000,15271000,-29643000,725289000.0,en-US,US,EQUITY,True,Delayed Quote,0.0,0.0,1630572224,200.38,96185,24.190002,0.13729498,176.19 - 227.07,-26.690002,-0.11754085,176.19,227.07,1620331200,1635937140,1636372800,46.287827,71.761,195.18143,5.198578,0.026634593,203.66093,-3.2809296,4251823360,25.428934,2,0.5166786,2.7923245,15,America/New_York,EDT,-14400000,198.475 - 200.59,199.35,200.38,260.0,8,8,finmb_317440,NasdaqGS,"ICU Medical, Inc.",USD,113031,28.54416,USD,False,False,200.38,1630526402,1.0299988,199.86,200.59,198.475,38342,NMS,"ICU Medical, Inc.",0,us_market,PRE,4.329,7.88,7.02,-0.016109765,0.59,,,227.07,176.19,195.18,203.66,113.03k,96.19k,21.22M,,19.92M,6.43%,96.77%,415.29k,3.89,2.84%,1.96%,440.63k,,,,,,0.00%,,,3:2,"Mar 17, 2002","Dec 30, 2020","Mar 30, 2021",7.44%,9.98%,4.39%,6.47%,1.26B,60.02,-3.20%,461.5M,212.64M,93.77M,4.33,41.00%,437.28M,20.63,51.37M,3.38,5.16,71.76,234.55M,149.25M,Value,92673,Healthcare,7900,5,3,"ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.",San Clemente,949 366 2183,CA,5,1609372800,1625011200,3,United States,http://www.icumed.com,86400,4,951 Calle Amanecer,949 366 8368,Medical Instruments & Supplies
t-2,ICUI,1219141000.0,21218800,10126000,,26166000,,24986000,70854000,113924000,32944000,32944000,,-645000,,,,1180000,318567000,285623000,204643000,-6778000,,24986000,24986000,200428000.0,683326000.0,277316000.0,1452220000.0,15891000.0,1729536000.0,2097000.0,26369000.0,782510000.0,47171000.0,32651000.0,-15713000.0,89439000.0,350993000.0,185359000.0,36373000.0,-15533000.0,506879000.0,900139000.0,,13878000.0,168520000.0,321961000.0,81027000.0,1979000,-14727000,-24080000,-150115000,-148588000,-7260000,1787000,-95141000,-260000,2041000,75486000,23794000,378000,33640000,18003000,-23845000,714780000.0,en-US,US,EQUITY,True,Delayed Quote,0.0,0.0,1630572224,200.38,96185,24.190002,0.13729498,176.19 - 227.07,-26.690002,-0.11754085,176.19,227.07,1620331200,1635937140,1636372800,46.287827,71.761,195.18143,5.198578,0.026634593,203.66093,-3.2809296,4251823360,25.428934,2,0.5166786,2.7923245,15,America/New_York,EDT,-14400000,198.475 - 200.59,199.35,200.38,260.0,8,8,finmb_317440,NasdaqGS,"ICU Medical, Inc.",USD,113031,28.54416,USD,False,False,200.38,1630526402,1.0299988,199.86,200.59,198.475,38342,NMS,"ICU Medical, Inc.",0,us_market,PRE,4.329,7.88,7.02,-0.016109765,0.59,,,227.07,176.19,195.18,203.66,113.03k,96.19k,21.22M,,19.92M,6.43%,96.77%,415.29k,3.89,2.84%,1.96%,440.63k,,,,,,0.00%,,,3:2,"Mar 17, 2002","Dec 30, 2020","Mar 30, 2021",7.44%,9.98%,4.39%,6.47%,1.26B,60.02,-3.20%,461.5M,212.64M,93.77M,4.33,41.00%,437.28M,20.63,51.37M,3.38,5.16,71.76,234.55M,149.25M,Value,92673,Healthcare,7900,5,3,"ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.",San Clemente,949 366 2183,CA,5,1609372800,1625011200,3,United States,http://www.icumed.com,86400,4,951 Calle Amanecer,949 366 8368,Medical Instruments & Supplies
t-3,ICUI,1175605000.0,21218800,10279000,,20838000,,18908000,67242000,106284000,28763000,28763000,,-797000,,,,1930000,303379000,274616000,197095000,-7925000,,18908000,18908000,203720000.0,675497000.0,447265000.0,1411797000.0,23105000.0,1859062000.0,2094000.0,31073000.0,757524000.0,41535000.0,32472000.0,-23318000.0,81629000.0,446134000.0,359151000.0,28776000.0,-23178000.0,504536000.0,1036705000.0,,15891000.0,201766000.0,322766000.0,101127000.0,5500000,11758000,-9684000,-116000,5736000,-28510000,6239000,26577000,-387000,1304000,29221000,23840000,-10891000,4394000,9318000,-13054000,677554000.0,en-US,US,EQUITY,True,Delayed Quote,0.0,0.0,1630572224,200.38,96185,24.190002,0.13729498,176.19 - 227.07,-26.690002,-0.11754085,176.19,227.07,1620331200,1635937140,1636372800,46.287827,71.761,195.18143,5.198578,0.026634593,203.66093,-3.2809296,4251823360,25.428934,2,0.5166786,2.7923245,15,America/New_York,EDT,-14400000,198.475 - 200.59,199.35,200.38,260.0,8,8,finmb_317440,NasdaqGS,"ICU Medical, Inc.",USD,113031,28.54416,USD,False,False,200.38,1630526402,1.0299988,199.86,200.59,198.475,38342,NMS,"ICU Medical, Inc.",0,us_market,PRE,4.329,7.88,7.02,-0.016109765,0.59,,,227.07,176.19,195.18,203.66,113.03k,96.19k,21.22M,,19.92M,6.43%,96.77%,415.29k,3.89,2.84%,1.96%,440.63k,,,,,,0.00%,,,3:2,"Mar 17, 2002","Dec 30, 2020","Mar 30, 2021",7.44%,9.98%,4.39%,6.47%,1.26B,60.02,-3.20%,461.5M,212.64M,93.77M,4.33,41.00%,437.28M,20.63,51.37M,3.38,5.16,71.76,234.55M,149.25M,Value,92673,Healthcare,7900,5,3,"ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.",San Clemente,949 366 2183,CA,5,1609372800,1625011200,3,United States,http://www.icumed.com,86400,4,951 Calle Amanecer,949 366 8368,Medical Instruments & Supplies
